Grey Matter Neurosciences
Latest round
- Seed
Last raised
- Jan 2025
Total raised
- $14M
Investors
- 4
About Grey Matter Neurosciences
Grey Matter Neurosciences focuses on advancing non-invasive therapeutic solutions for cognitive decline. The firm has one global office located in Toronto, Canada. The founder's previous entrepreneurial experience is not publicly detailed. Grey Matter Neurosciences is focused on the innovative development of a portable ultrasound helmet designed to enhance brain function, specifically targeting Alzheimer's disease. This unique product utilizes advanced focused ultrasound technology to provide non-invasive therapeutic solutions aimed at restoring cognitive capabilities in seniors. The helmet is intended for use in clinical environments and potentially at home, catering to elderly patients experiencing early to moderate stages of cognitive decline. By targeting Alzheimer's disease, Grey Matter Neurosciences seeks to address a significant healthcare challenge, providing an accessible solution for patients and their caregivers. The company aims to penetrate markets in North America and Europe, where there is a notable demand for Alzheimer's treatment solutions. The revenue model for Grey Matter Neurosciences is structured around direct-to-consumer sales and potential partnerships with healthcare providers. The company anticipates revenue generation through the sale of its ultrasound helmet, which will be priced to reflect its innovative technology and the value it offers to users. The sales process involves transactions with healthcare facilities, rehabilitation centers, and direct consumers, creating a streamlined approach to market its flagship product. As the company develops its product, it may also explore subscription models for ongoing support or services related to the use of the ultrasound helmet, thereby establishing a continuing revenue stream from its client base. Future growth plans include launching the portable ultrasound helmet, specifically designed for treating Alzheimer’s patients, while targeting expansion into North American and European markets by 2026. This strategy reflects a commitment to addressing the healthcare challenges faced by individuals with cognitive decline.
Who invested in Grey Matter Neurosciences
4 investors across 1 round
See all investors in Grey Matter Neurosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 20, 2025
Amount
$14M
Investors
Questions about Grey Matter Neurosciences
Who invested in Grey Matter Neurosciences?
Grey Matter Neurosciences has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Grey Matter Neurosciences raised?
Grey Matter Neurosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Grey Matter Neurosciences last raise money?
Grey Matter Neurosciences's most recent round on record is a Seed, in Jan 2025.
What does Grey Matter Neurosciences do?
Grey Matter Neurosciences focuses on advancing non-invasive therapeutic solutions for cognitive decline.
Where is Grey Matter Neurosciences headquartered?
Grey Matter Neurosciences is headquartered in Toronto, Canada.
Which VCs invest in companies like Grey Matter Neurosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Grey Matter Neurosciences's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Grey Matter Neurosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.